DFCM
TARS icon

Dark Forest Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Dark Forest Capital Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,062
Closed -$301K – 1335
2025
Q3 		$301K Sell
5,062
-5,990
-54% -$295K 0.01% 1022
2025
Q2 		$448K Buy
+11,052
New +$497K 0.02% 956
2024
Q3 		– Sell
-7,429
Closed -$202K – 1148
2024
Q2 		$202K Buy
+7,429
New +$250K 0.04% 575

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Dark Forest Capital Management's TARS Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Tarsus Pharmaceuticals (TARS) in Q4 2025, closing a stake of 5,062 shares — an estimated $301K sold.

Dark Forest Capital Management first reported a position in TARS in Q2 2024 and held it in 3 quarters. The position peaked at $448K in Q2 2025. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • Dark Forest Capital Management reported no remaining Tarsus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 5,062 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $301K.
  • Dark Forest Capital Management first reported a position in Tarsus Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Dark Forest Capital Management's Tarsus Pharmaceuticals position peaked at $448K in Q2 2025.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.